nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbinafine—Naftifine—Tamoxifen—pancreatic cancer	0.415	1	CrCrCtD
Terbinafine—CYP19A1—Tamoxifen—pancreatic cancer	0.096	0.229	CbGbCtD
Terbinafine—CYP2C8—Tamoxifen—pancreatic cancer	0.03	0.0717	CbGbCtD
Terbinafine—CYP1A2—Dacarbazine—pancreatic cancer	0.0292	0.0698	CbGbCtD
Terbinafine—CYP2C8—Erlotinib—pancreatic cancer	0.0255	0.061	CbGbCtD
Terbinafine—CYP2C19—Tamoxifen—pancreatic cancer	0.0252	0.0601	CbGbCtD
Terbinafine—CYP1A2—Tamoxifen—pancreatic cancer	0.0232	0.0555	CbGbCtD
Terbinafine—CYP2C8—Fluorouracil—pancreatic cancer	0.0221	0.0528	CbGbCtD
Terbinafine—CYP2C9—Tamoxifen—pancreatic cancer	0.0209	0.05	CbGbCtD
Terbinafine—CYP1A2—Erlotinib—pancreatic cancer	0.0197	0.0472	CbGbCtD
Terbinafine—CYP2D6—Tamoxifen—pancreatic cancer	0.0191	0.0457	CbGbCtD
Terbinafine—CYP1A2—Fluorouracil—pancreatic cancer	0.0171	0.0409	CbGbCtD
Terbinafine—CYP2D6—Erlotinib—pancreatic cancer	0.0163	0.0389	CbGbCtD
Terbinafine—CYP2C9—Fluorouracil—pancreatic cancer	0.0154	0.0368	CbGbCtD
Terbinafine—CYP3A4—Tamoxifen—pancreatic cancer	0.0122	0.0291	CbGbCtD
Terbinafine—CYP3A4—Erlotinib—pancreatic cancer	0.0103	0.0247	CbGbCtD
Terbinafine—CYP3A4—Irinotecan—pancreatic cancer	0.00934	0.0223	CbGbCtD
Terbinafine—CYP2D6—Doxorubicin—pancreatic cancer	0.00802	0.0192	CbGbCtD
Terbinafine—CYP3A4—Docetaxel—pancreatic cancer	0.00684	0.0164	CbGbCtD
Terbinafine—CYP3A4—Sunitinib—pancreatic cancer	0.00681	0.0163	CbGbCtD
Terbinafine—CYP3A4—Doxorubicin—pancreatic cancer	0.0051	0.0122	CbGbCtD
Terbinafine—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00016	0.000963	CcSEcCtD
Terbinafine—Asthenia—Sunitinib—pancreatic cancer	0.00016	0.000962	CcSEcCtD
Terbinafine—Decreased appetite—Irinotecan—pancreatic cancer	0.00016	0.00096	CcSEcCtD
Terbinafine—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000159	0.000956	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000159	0.000953	CcSEcCtD
Terbinafine—Fatigue—Irinotecan—pancreatic cancer	0.000158	0.000952	CcSEcCtD
Terbinafine—Paraesthesia—Fluorouracil—pancreatic cancer	0.000158	0.000949	CcSEcCtD
Terbinafine—Alopecia—Docetaxel—pancreatic cancer	0.000158	0.000949	CcSEcCtD
Terbinafine—Pruritus—Sunitinib—pancreatic cancer	0.000158	0.000948	CcSEcCtD
Terbinafine—Pain—Irinotecan—pancreatic cancer	0.000157	0.000944	CcSEcCtD
Terbinafine—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000157	0.000943	CcSEcCtD
Terbinafine—Mental disorder—Docetaxel—pancreatic cancer	0.000157	0.000941	CcSEcCtD
Terbinafine—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000156	0.000936	CcSEcCtD
Terbinafine—Erythema—Docetaxel—pancreatic cancer	0.000156	0.000935	CcSEcCtD
Terbinafine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000156	0.000935	CcSEcCtD
Terbinafine—Dyspepsia—Fluorouracil—pancreatic cancer	0.000155	0.000931	CcSEcCtD
Terbinafine—Nausea—Tamoxifen—pancreatic cancer	0.000155	0.000929	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000155	0.000928	CcSEcCtD
Terbinafine—Fatigue—Gemcitabine—pancreatic cancer	0.000154	0.000927	CcSEcCtD
Terbinafine—Gastritis—Epirubicin—pancreatic cancer	0.000154	0.000927	CcSEcCtD
Terbinafine—Pain—Gemcitabine—pancreatic cancer	0.000153	0.00092	CcSEcCtD
Terbinafine—Nausea—Erlotinib—pancreatic cancer	0.000153	0.00092	CcSEcCtD
Terbinafine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000153	0.000919	CcSEcCtD
Terbinafine—Diarrhoea—Sunitinib—pancreatic cancer	0.000153	0.000917	CcSEcCtD
Terbinafine—Dysgeusia—Docetaxel—pancreatic cancer	0.000152	0.000916	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000152	0.000913	CcSEcCtD
Terbinafine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000151	0.00091	CcSEcCtD
Terbinafine—Influenza—Epirubicin—pancreatic cancer	0.000151	0.000905	CcSEcCtD
Terbinafine—Pain—Fluorouracil—pancreatic cancer	0.000151	0.000904	CcSEcCtD
Terbinafine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00015	0.000903	CcSEcCtD
Terbinafine—Muscle spasms—Docetaxel—pancreatic cancer	0.00015	0.000899	CcSEcCtD
Terbinafine—Eosinophilia—Epirubicin—pancreatic cancer	0.000149	0.000896	CcSEcCtD
Terbinafine—Pancreatitis—Epirubicin—pancreatic cancer	0.000148	0.000887	CcSEcCtD
Terbinafine—Dizziness—Sunitinib—pancreatic cancer	0.000148	0.000886	CcSEcCtD
Terbinafine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000148	0.000886	CcSEcCtD
Terbinafine—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000147	0.000885	CcSEcCtD
Terbinafine—Abdominal pain—Irinotecan—pancreatic cancer	0.000145	0.000873	CcSEcCtD
Terbinafine—Body temperature increased—Irinotecan—pancreatic cancer	0.000145	0.000873	CcSEcCtD
Terbinafine—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000145	0.000873	CcSEcCtD
Terbinafine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000145	0.000871	CcSEcCtD
Terbinafine—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000144	0.000866	CcSEcCtD
Terbinafine—Anaemia—Docetaxel—pancreatic cancer	0.000144	0.000864	CcSEcCtD
Terbinafine—Pancytopenia—Epirubicin—pancreatic cancer	0.000143	0.00086	CcSEcCtD
Terbinafine—Gastritis—Doxorubicin—pancreatic cancer	0.000143	0.000858	CcSEcCtD
Terbinafine—Vomiting—Sunitinib—pancreatic cancer	0.000142	0.000852	CcSEcCtD
Terbinafine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000142	0.00085	CcSEcCtD
Terbinafine—Neutropenia—Epirubicin—pancreatic cancer	0.000141	0.000846	CcSEcCtD
Terbinafine—Rash—Sunitinib—pancreatic cancer	0.000141	0.000845	CcSEcCtD
Terbinafine—Dermatitis—Sunitinib—pancreatic cancer	0.000141	0.000844	CcSEcCtD
Terbinafine—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.00014	0.000841	CcSEcCtD
Terbinafine—Urticaria—Fluorouracil—pancreatic cancer	0.00014	0.00084	CcSEcCtD
Terbinafine—Headache—Sunitinib—pancreatic cancer	0.00014	0.00084	CcSEcCtD
Terbinafine—Influenza—Doxorubicin—pancreatic cancer	0.000139	0.000837	CcSEcCtD
Terbinafine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000139	0.000836	CcSEcCtD
Terbinafine—Eosinophilia—Doxorubicin—pancreatic cancer	0.000138	0.000829	CcSEcCtD
Terbinafine—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000138	0.000826	CcSEcCtD
Terbinafine—Pancreatitis—Doxorubicin—pancreatic cancer	0.000137	0.000821	CcSEcCtD
Terbinafine—Weight decreased—Epirubicin—pancreatic cancer	0.000136	0.000819	CcSEcCtD
Terbinafine—Cough—Docetaxel—pancreatic cancer	0.000136	0.000816	CcSEcCtD
Terbinafine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000135	0.000813	CcSEcCtD
Terbinafine—Infestation—Epirubicin—pancreatic cancer	0.000134	0.000807	CcSEcCtD
Terbinafine—Infestation NOS—Epirubicin—pancreatic cancer	0.000134	0.000807	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000133	0.0008	CcSEcCtD
Terbinafine—Arthralgia—Docetaxel—pancreatic cancer	0.000133	0.000796	CcSEcCtD
Terbinafine—Chest pain—Docetaxel—pancreatic cancer	0.000133	0.000796	CcSEcCtD
Terbinafine—Myalgia—Docetaxel—pancreatic cancer	0.000133	0.000796	CcSEcCtD
Terbinafine—Nausea—Sunitinib—pancreatic cancer	0.000133	0.000796	CcSEcCtD
Terbinafine—Pancytopenia—Doxorubicin—pancreatic cancer	0.000132	0.000795	CcSEcCtD
Terbinafine—Asthenia—Irinotecan—pancreatic cancer	0.000132	0.000792	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000132	0.000791	CcSEcCtD
Terbinafine—Jaundice—Epirubicin—pancreatic cancer	0.000131	0.000787	CcSEcCtD
Terbinafine—Neutropenia—Doxorubicin—pancreatic cancer	0.00013	0.000783	CcSEcCtD
Terbinafine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00013	0.000779	CcSEcCtD
Terbinafine—Dry mouth—Docetaxel—pancreatic cancer	0.00013	0.000779	CcSEcCtD
Terbinafine—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.00013	0.000778	CcSEcCtD
Terbinafine—Asthenia—Gemcitabine—pancreatic cancer	0.000128	0.000772	CcSEcCtD
Terbinafine—Confusional state—Docetaxel—pancreatic cancer	0.000128	0.000769	CcSEcCtD
Terbinafine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000127	0.000764	CcSEcCtD
Terbinafine—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000127	0.000763	CcSEcCtD
Terbinafine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000127	0.000763	CcSEcCtD
Terbinafine—Pruritus—Gemcitabine—pancreatic cancer	0.000127	0.000761	CcSEcCtD
Terbinafine—Infection—Docetaxel—pancreatic cancer	0.000126	0.000758	CcSEcCtD
Terbinafine—Weight decreased—Doxorubicin—pancreatic cancer	0.000126	0.000758	CcSEcCtD
Terbinafine—Diarrhoea—Irinotecan—pancreatic cancer	0.000126	0.000755	CcSEcCtD
Terbinafine—Agranulocytosis—Epirubicin—pancreatic cancer	0.000125	0.000753	CcSEcCtD
Terbinafine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000125	0.000748	CcSEcCtD
Terbinafine—Pruritus—Fluorouracil—pancreatic cancer	0.000125	0.000748	CcSEcCtD
Terbinafine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000124	0.000747	CcSEcCtD
Terbinafine—Infestation NOS—Doxorubicin—pancreatic cancer	0.000124	0.000747	CcSEcCtD
Terbinafine—Infestation—Doxorubicin—pancreatic cancer	0.000124	0.000747	CcSEcCtD
Terbinafine—Skin disorder—Docetaxel—pancreatic cancer	0.000123	0.000741	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000123	0.00074	CcSEcCtD
Terbinafine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000122	0.000736	CcSEcCtD
Terbinafine—Dizziness—Irinotecan—pancreatic cancer	0.000122	0.00073	CcSEcCtD
Terbinafine—Jaundice—Doxorubicin—pancreatic cancer	0.000121	0.000728	CcSEcCtD
Terbinafine—Anorexia—Docetaxel—pancreatic cancer	0.000121	0.000727	CcSEcCtD
Terbinafine—Hepatitis—Epirubicin—pancreatic cancer	0.000121	0.000724	CcSEcCtD
Terbinafine—Diarrhoea—Fluorouracil—pancreatic cancer	0.00012	0.000723	CcSEcCtD
Terbinafine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.00012	0.000721	CcSEcCtD
Terbinafine—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000119	0.000712	CcSEcCtD
Terbinafine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000118	0.000706	CcSEcCtD
Terbinafine—Vomiting—Irinotecan—pancreatic cancer	0.000117	0.000702	CcSEcCtD
Terbinafine—Dizziness—Fluorouracil—pancreatic cancer	0.000116	0.000699	CcSEcCtD
Terbinafine—Visual impairment—Epirubicin—pancreatic cancer	0.000116	0.000698	CcSEcCtD
Terbinafine—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000116	0.000697	CcSEcCtD
Terbinafine—Rash—Irinotecan—pancreatic cancer	0.000116	0.000696	CcSEcCtD
Terbinafine—Dermatitis—Irinotecan—pancreatic cancer	0.000116	0.000695	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000116	0.000695	CcSEcCtD
Terbinafine—Headache—Irinotecan—pancreatic cancer	0.000115	0.000692	CcSEcCtD
Terbinafine—Paraesthesia—Docetaxel—pancreatic cancer	0.000114	0.000685	CcSEcCtD
Terbinafine—Erythema multiforme—Epirubicin—pancreatic cancer	0.000114	0.000685	CcSEcCtD
Terbinafine—Vomiting—Gemcitabine—pancreatic cancer	0.000114	0.000684	CcSEcCtD
Terbinafine—Rash—Gemcitabine—pancreatic cancer	0.000113	0.000678	CcSEcCtD
Terbinafine—Dermatitis—Gemcitabine—pancreatic cancer	0.000113	0.000677	CcSEcCtD
Terbinafine—Eye disorder—Epirubicin—pancreatic cancer	0.000113	0.000677	CcSEcCtD
Terbinafine—Tinnitus—Epirubicin—pancreatic cancer	0.000112	0.000675	CcSEcCtD
Terbinafine—Headache—Gemcitabine—pancreatic cancer	0.000112	0.000674	CcSEcCtD
Terbinafine—Vomiting—Fluorouracil—pancreatic cancer	0.000112	0.000672	CcSEcCtD
Terbinafine—Dyspepsia—Docetaxel—pancreatic cancer	0.000112	0.000672	CcSEcCtD
Terbinafine—Hepatitis—Doxorubicin—pancreatic cancer	0.000112	0.00067	CcSEcCtD
Terbinafine—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000111	0.000667	CcSEcCtD
Terbinafine—Rash—Fluorouracil—pancreatic cancer	0.000111	0.000667	CcSEcCtD
Terbinafine—Dermatitis—Fluorouracil—pancreatic cancer	0.000111	0.000666	CcSEcCtD
Terbinafine—Decreased appetite—Docetaxel—pancreatic cancer	0.00011	0.000663	CcSEcCtD
Terbinafine—Headache—Fluorouracil—pancreatic cancer	0.00011	0.000662	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00011	0.000659	CcSEcCtD
Terbinafine—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.00011	0.000659	CcSEcCtD
Terbinafine—Fatigue—Docetaxel—pancreatic cancer	0.00011	0.000658	CcSEcCtD
Terbinafine—Angiopathy—Epirubicin—pancreatic cancer	0.000109	0.000657	CcSEcCtD
Terbinafine—Nausea—Irinotecan—pancreatic cancer	0.000109	0.000656	CcSEcCtD
Terbinafine—Immune system disorder—Epirubicin—pancreatic cancer	0.000109	0.000654	CcSEcCtD
Terbinafine—Pain—Docetaxel—pancreatic cancer	0.000109	0.000653	CcSEcCtD
Terbinafine—Visual impairment—Doxorubicin—pancreatic cancer	0.000108	0.000646	CcSEcCtD
Terbinafine—Alopecia—Epirubicin—pancreatic cancer	0.000107	0.00064	CcSEcCtD
Terbinafine—Nausea—Gemcitabine—pancreatic cancer	0.000106	0.000639	CcSEcCtD
Terbinafine—Mental disorder—Epirubicin—pancreatic cancer	0.000106	0.000635	CcSEcCtD
Terbinafine—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000106	0.000634	CcSEcCtD
Terbinafine—Erythema—Epirubicin—pancreatic cancer	0.000105	0.000631	CcSEcCtD
Terbinafine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000105	0.000629	CcSEcCtD
Terbinafine—Nausea—Fluorouracil—pancreatic cancer	0.000105	0.000628	CcSEcCtD
Terbinafine—Eye disorder—Doxorubicin—pancreatic cancer	0.000104	0.000626	CcSEcCtD
Terbinafine—Tinnitus—Doxorubicin—pancreatic cancer	0.000104	0.000625	CcSEcCtD
Terbinafine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000104	0.000624	CcSEcCtD
Terbinafine—Flatulence—Epirubicin—pancreatic cancer	0.000103	0.000621	CcSEcCtD
Terbinafine—Dysgeusia—Epirubicin—pancreatic cancer	0.000103	0.000618	CcSEcCtD
Terbinafine—Angiopathy—Doxorubicin—pancreatic cancer	0.000101	0.000608	CcSEcCtD
Terbinafine—Muscle spasms—Epirubicin—pancreatic cancer	0.000101	0.000606	CcSEcCtD
Terbinafine—Immune system disorder—Doxorubicin—pancreatic cancer	0.000101	0.000605	CcSEcCtD
Terbinafine—Body temperature increased—Docetaxel—pancreatic cancer	0.0001	0.000603	CcSEcCtD
Terbinafine—Abdominal pain—Docetaxel—pancreatic cancer	0.0001	0.000603	CcSEcCtD
Terbinafine—Vision blurred—Epirubicin—pancreatic cancer	9.9e-05	0.000594	CcSEcCtD
Terbinafine—Alopecia—Doxorubicin—pancreatic cancer	9.86e-05	0.000592	CcSEcCtD
Terbinafine—Mental disorder—Doxorubicin—pancreatic cancer	9.78e-05	0.000587	CcSEcCtD
Terbinafine—Ill-defined disorder—Epirubicin—pancreatic cancer	9.74e-05	0.000585	CcSEcCtD
Terbinafine—Erythema—Doxorubicin—pancreatic cancer	9.72e-05	0.000584	CcSEcCtD
Terbinafine—Anaemia—Epirubicin—pancreatic cancer	9.7e-05	0.000583	CcSEcCtD
Terbinafine—Flatulence—Doxorubicin—pancreatic cancer	9.57e-05	0.000575	CcSEcCtD
Terbinafine—Dysgeusia—Doxorubicin—pancreatic cancer	9.51e-05	0.000571	CcSEcCtD
Terbinafine—Malaise—Epirubicin—pancreatic cancer	9.47e-05	0.000569	CcSEcCtD
Terbinafine—Vertigo—Epirubicin—pancreatic cancer	9.43e-05	0.000567	CcSEcCtD
Terbinafine—Hypersensitivity—Docetaxel—pancreatic cancer	9.36e-05	0.000562	CcSEcCtD
Terbinafine—Muscle spasms—Doxorubicin—pancreatic cancer	9.34e-05	0.000561	CcSEcCtD
Terbinafine—Cough—Epirubicin—pancreatic cancer	9.16e-05	0.00055	CcSEcCtD
Terbinafine—Vision blurred—Doxorubicin—pancreatic cancer	9.16e-05	0.00055	CcSEcCtD
Terbinafine—Asthenia—Docetaxel—pancreatic cancer	9.12e-05	0.000548	CcSEcCtD
Terbinafine—Ill-defined disorder—Doxorubicin—pancreatic cancer	9.01e-05	0.000541	CcSEcCtD
Terbinafine—Pruritus—Docetaxel—pancreatic cancer	8.99e-05	0.00054	CcSEcCtD
Terbinafine—Anaemia—Doxorubicin—pancreatic cancer	8.98e-05	0.000539	CcSEcCtD
Terbinafine—Chest pain—Epirubicin—pancreatic cancer	8.94e-05	0.000537	CcSEcCtD
Terbinafine—Arthralgia—Epirubicin—pancreatic cancer	8.94e-05	0.000537	CcSEcCtD
Terbinafine—Myalgia—Epirubicin—pancreatic cancer	8.94e-05	0.000537	CcSEcCtD
Terbinafine—Anxiety—Epirubicin—pancreatic cancer	8.91e-05	0.000535	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	8.88e-05	0.000533	CcSEcCtD
Terbinafine—Discomfort—Epirubicin—pancreatic cancer	8.83e-05	0.00053	CcSEcCtD
Terbinafine—Malaise—Doxorubicin—pancreatic cancer	8.76e-05	0.000526	CcSEcCtD
Terbinafine—Dry mouth—Epirubicin—pancreatic cancer	8.74e-05	0.000525	CcSEcCtD
Terbinafine—Vertigo—Doxorubicin—pancreatic cancer	8.73e-05	0.000524	CcSEcCtD
Terbinafine—Diarrhoea—Docetaxel—pancreatic cancer	8.69e-05	0.000522	CcSEcCtD
Terbinafine—Confusional state—Epirubicin—pancreatic cancer	8.64e-05	0.000519	CcSEcCtD
Terbinafine—Anaphylactic shock—Epirubicin—pancreatic cancer	8.57e-05	0.000515	CcSEcCtD
Terbinafine—Infection—Epirubicin—pancreatic cancer	8.51e-05	0.000511	CcSEcCtD
Terbinafine—Cough—Doxorubicin—pancreatic cancer	8.48e-05	0.000509	CcSEcCtD
Terbinafine—Nervous system disorder—Epirubicin—pancreatic cancer	8.4e-05	0.000505	CcSEcCtD
Terbinafine—Dizziness—Docetaxel—pancreatic cancer	8.4e-05	0.000505	CcSEcCtD
Terbinafine—Thrombocytopenia—Epirubicin—pancreatic cancer	8.39e-05	0.000504	CcSEcCtD
Terbinafine—Skin disorder—Epirubicin—pancreatic cancer	8.32e-05	0.0005	CcSEcCtD
Terbinafine—Chest pain—Doxorubicin—pancreatic cancer	8.27e-05	0.000497	CcSEcCtD
Terbinafine—Arthralgia—Doxorubicin—pancreatic cancer	8.27e-05	0.000497	CcSEcCtD
Terbinafine—Myalgia—Doxorubicin—pancreatic cancer	8.27e-05	0.000497	CcSEcCtD
Terbinafine—Anxiety—Doxorubicin—pancreatic cancer	8.24e-05	0.000495	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	8.21e-05	0.000493	CcSEcCtD
Terbinafine—Discomfort—Doxorubicin—pancreatic cancer	8.17e-05	0.000491	CcSEcCtD
Terbinafine—Anorexia—Epirubicin—pancreatic cancer	8.17e-05	0.000491	CcSEcCtD
Terbinafine—Dry mouth—Doxorubicin—pancreatic cancer	8.09e-05	0.000486	CcSEcCtD
Terbinafine—Vomiting—Docetaxel—pancreatic cancer	8.08e-05	0.000485	CcSEcCtD
Terbinafine—Rash—Docetaxel—pancreatic cancer	8.01e-05	0.000481	CcSEcCtD
Terbinafine—Dermatitis—Docetaxel—pancreatic cancer	8e-05	0.000481	CcSEcCtD
Terbinafine—Confusional state—Doxorubicin—pancreatic cancer	8e-05	0.00048	CcSEcCtD
Terbinafine—Headache—Docetaxel—pancreatic cancer	7.96e-05	0.000478	CcSEcCtD
Terbinafine—Anaphylactic shock—Doxorubicin—pancreatic cancer	7.93e-05	0.000476	CcSEcCtD
Terbinafine—Infection—Doxorubicin—pancreatic cancer	7.88e-05	0.000473	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	7.81e-05	0.000469	CcSEcCtD
Terbinafine—Nervous system disorder—Doxorubicin—pancreatic cancer	7.78e-05	0.000467	CcSEcCtD
Terbinafine—Thrombocytopenia—Doxorubicin—pancreatic cancer	7.76e-05	0.000466	CcSEcCtD
Terbinafine—Skin disorder—Doxorubicin—pancreatic cancer	7.7e-05	0.000463	CcSEcCtD
Terbinafine—Paraesthesia—Epirubicin—pancreatic cancer	7.69e-05	0.000462	CcSEcCtD
Terbinafine—Anorexia—Doxorubicin—pancreatic cancer	7.56e-05	0.000454	CcSEcCtD
Terbinafine—Nausea—Docetaxel—pancreatic cancer	7.55e-05	0.000453	CcSEcCtD
Terbinafine—Dyspepsia—Epirubicin—pancreatic cancer	7.54e-05	0.000453	CcSEcCtD
Terbinafine—Decreased appetite—Epirubicin—pancreatic cancer	7.45e-05	0.000447	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	7.4e-05	0.000444	CcSEcCtD
Terbinafine—Fatigue—Epirubicin—pancreatic cancer	7.39e-05	0.000444	CcSEcCtD
Terbinafine—Pain—Epirubicin—pancreatic cancer	7.33e-05	0.00044	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	7.22e-05	0.000434	CcSEcCtD
Terbinafine—Paraesthesia—Doxorubicin—pancreatic cancer	7.12e-05	0.000428	CcSEcCtD
Terbinafine—Feeling abnormal—Epirubicin—pancreatic cancer	7.06e-05	0.000424	CcSEcCtD
Terbinafine—Gastrointestinal pain—Epirubicin—pancreatic cancer	7.01e-05	0.000421	CcSEcCtD
Terbinafine—Dyspepsia—Doxorubicin—pancreatic cancer	6.98e-05	0.000419	CcSEcCtD
Terbinafine—Decreased appetite—Doxorubicin—pancreatic cancer	6.89e-05	0.000414	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	6.85e-05	0.000411	CcSEcCtD
Terbinafine—Fatigue—Doxorubicin—pancreatic cancer	6.84e-05	0.000411	CcSEcCtD
Terbinafine—Urticaria—Epirubicin—pancreatic cancer	6.81e-05	0.000409	CcSEcCtD
Terbinafine—Pain—Doxorubicin—pancreatic cancer	6.78e-05	0.000407	CcSEcCtD
Terbinafine—Abdominal pain—Epirubicin—pancreatic cancer	6.77e-05	0.000407	CcSEcCtD
Terbinafine—Body temperature increased—Epirubicin—pancreatic cancer	6.77e-05	0.000407	CcSEcCtD
Terbinafine—Feeling abnormal—Doxorubicin—pancreatic cancer	6.53e-05	0.000392	CcSEcCtD
Terbinafine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	6.48e-05	0.000389	CcSEcCtD
Terbinafine—Hypersensitivity—Epirubicin—pancreatic cancer	6.31e-05	0.000379	CcSEcCtD
Terbinafine—Urticaria—Doxorubicin—pancreatic cancer	6.3e-05	0.000378	CcSEcCtD
Terbinafine—Body temperature increased—Doxorubicin—pancreatic cancer	6.27e-05	0.000376	CcSEcCtD
Terbinafine—Abdominal pain—Doxorubicin—pancreatic cancer	6.27e-05	0.000376	CcSEcCtD
Terbinafine—Asthenia—Epirubicin—pancreatic cancer	6.15e-05	0.000369	CcSEcCtD
Terbinafine—Pruritus—Epirubicin—pancreatic cancer	6.06e-05	0.000364	CcSEcCtD
Terbinafine—Diarrhoea—Epirubicin—pancreatic cancer	5.86e-05	0.000352	CcSEcCtD
Terbinafine—Hypersensitivity—Doxorubicin—pancreatic cancer	5.84e-05	0.000351	CcSEcCtD
Terbinafine—Asthenia—Doxorubicin—pancreatic cancer	5.69e-05	0.000342	CcSEcCtD
Terbinafine—Dizziness—Epirubicin—pancreatic cancer	5.67e-05	0.00034	CcSEcCtD
Terbinafine—Pruritus—Doxorubicin—pancreatic cancer	5.61e-05	0.000337	CcSEcCtD
Terbinafine—Vomiting—Epirubicin—pancreatic cancer	5.45e-05	0.000327	CcSEcCtD
Terbinafine—Diarrhoea—Doxorubicin—pancreatic cancer	5.43e-05	0.000326	CcSEcCtD
Terbinafine—Rash—Epirubicin—pancreatic cancer	5.4e-05	0.000325	CcSEcCtD
Terbinafine—Dermatitis—Epirubicin—pancreatic cancer	5.4e-05	0.000324	CcSEcCtD
Terbinafine—Headache—Epirubicin—pancreatic cancer	5.37e-05	0.000322	CcSEcCtD
Terbinafine—Dizziness—Doxorubicin—pancreatic cancer	5.24e-05	0.000315	CcSEcCtD
Terbinafine—Nausea—Epirubicin—pancreatic cancer	5.09e-05	0.000306	CcSEcCtD
Terbinafine—Vomiting—Doxorubicin—pancreatic cancer	5.04e-05	0.000303	CcSEcCtD
Terbinafine—Rash—Doxorubicin—pancreatic cancer	5e-05	0.0003	CcSEcCtD
Terbinafine—Dermatitis—Doxorubicin—pancreatic cancer	4.99e-05	0.0003	CcSEcCtD
Terbinafine—Headache—Doxorubicin—pancreatic cancer	4.97e-05	0.000298	CcSEcCtD
Terbinafine—Nausea—Doxorubicin—pancreatic cancer	4.71e-05	0.000283	CcSEcCtD
